Health has always been an area in which Air Liquide Canada has invested, as evidenced by our numerous products for the health sector and patients. In keeping with this spirit, Air Liquide Canada President and CEO Adam Peters confirmed a donation of $50,000 to the Neonatal Intensive Care Unit of the new Montreal Children's Hospital. With this donation, Air Liquide Canada is contributing to the well-being of the community by investing in the development of durable infrastructures for health care.
The new building housing the Montreal Children's Hospital, part of the McGill University Health Centre, is scheduled to open its doors in 2015. From 2012 to 2014, ALC will contribute an amount totalling $50,000 toward the construction of the Neonatal Intensive Care Unit. The news was made official by Adam Peters on October 11 during his visit to the hospital. For the occasion, Dr. Thérèse Perreault, Director, Newborn Medicine, gave Mr. Peters a tour of the current unit followed by a description of the future facility, including the numerous advantages it will offer.
"I was impressed by the extremely positive changes that this new unit will bring to the care of critically ill newborns," said Adam Peters. "Helping to improve the health of our children is an investment in the future and demonstrates our involvement in our community."
Air Liquide is the world leader in gases for industry, health and the environment, and is present in 80 countries with 46,200 employees. Oxygen, nitrogen, hydrogen and rare gases have been at the core of Air Liquide’s activities since its creation in 1902. Using these molecules, Air Liquide continuously reinvents its business, anticipating the needs of current and future markets. The Group innovates to enable progress, to achieve dynamic growth and a consistent performance.
Innovative technologies that curb polluting emissions, lower industry’s energy use, recover and reuse natural resources or develop the energies of tomorrow, such as hydrogen, biofuels or photovoltaic energy… Oxygen for hospitals, homecare, fighting nosocomial infections… Air Liquide combines many products and technologies to develop valuable applications and services not only for its customers but also for society.
A partner for the long term, Air Liquide relies on employee commitment, customer trust and shareholder support to pursue its vision of sustainable, competitive growth. The diversity of Air Liquide’s teams, businesses, markets and geographic presence provides a solid and sustainable base for its development and strengthens its ability to push back its own limits, conquer new territories and build its future.
Air Liquide explores the best that air can offer to preserve life, staying true to its Corporate Social Responsibility and sustainable development approach. In 2011, the Group’s revenues amounted to €14.5 billion, of which more than 80% were generated outside France. Air Liquide is listed on the Paris Euronext stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones Euro Stoxx 50 indexes.
Founded in 1911, Air Liquide Canada has over 2200 employees and serves over 80,000 customers in Canada. From coast to coast, our sites are located in key industrial regions. Air Liquide provides services and products to the health sector, for example molecules used by laboratories and hospitals. Its subsidiary VitalAire also caters services directly to hospitals and at-home patients.
